The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Weight Loss Timeline in the UK
If you're considering Mounjaro as a weekly weight loss injection in the UK, understanding the realistic timeline is essential. Most people begin noticing weight loss changes around week 4–8, though individual results vary significantly. This guide explains what to expect at each stage, NHS eligibility criteria, and how Mounjaro (tirzepatide) works differently from other prescription weight loss treatments like Wegovy. The timeline depends on your starting dose, how your body responds, and adherence to reduced-calorie diet and increased physical activity.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Eligibility and UK Timeline Expectations
In the UK, Mounjaro is a prescription-only weight loss injection available through NHS specialist tier 3 weight management services or private online prescribing following clinical assessment. NICE has approved tirzepatide for use within the NHS, though regional availability varies significantly—some areas have substantial waiting lists.
Week-by-week expectations:
- Weeks 1–4 (starting dose 2.5 mg): Nausea and appetite reduction common; minimal weight loss yet
- Weeks 5–8 (dose escalation to 5 mg): Most people notice reduced hunger; modest weight loss begins (~1–2 kg)
- Weeks 9–16 (further dose increases): More consistent weekly weight loss; average 0.5–1 kg per week
- Weeks 17+ (maintenance doses 10–15 mg): Weight loss typically plateaus; best results at maximum tolerated dose
Clinical trial data (SURMOUNT-1) showed average weight loss of 15–21% body weight over 72 weeks at various doses, alongside diet and exercise. Individual results vary widely—some people lose weight steadily, others experience plateaus.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS vs Private Access and Timeline Differences
NHS route: Access through your GP with referral to tier 3 specialist services. Waiting times vary from months to years depending on your region (ICB). Once prescribed, you receive your Mounjaro KwikPen via NHS pharmacy. The dose titration schedule remains the same regardless of route.
Private route: Faster access—complete an online clinical assessment with a UK-licensed prescriber and receive your prescription within days if approved. Dispensed by a GPhC-registered pharmacy. This route removes NHS waiting list delays but involves out-of-pocket costs.
Calculate your potential weight loss expectations using our free GLP-1 weight loss calculator. Track your actual progress weekly with our progress tracker to monitor whether you're on pace with clinical trial averages.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
When will I start losing weight on Mounjaro?
Most people notice appetite reduction within days to weeks 1–2, but measurable weight loss typically begins around week 4–8 as doses increase. The starting dose (2.5 mg) may cause nausea but produces minimal weight loss. Significant weight loss usually becomes apparent after reaching the 5 mg or 7.5 mg dose. Individual timelines vary—patience and consistency are essential.
How much weight can I expect to lose in the first month on Mounjaro?
In the first month (weeks 1–4), most people experience minimal weight loss, typically 0–2 kg. The focus is on dose tolerance and managing side effects like nausea. Real weight loss momentum builds in weeks 5–12 as doses increase. Clinical trials showed average loss accelerated from week 4 onwards when participants combined Mounjaro with reduced-calorie diet and exercise.
Is Mounjaro faster than Wegovy for weight loss?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, while Wegovy (semaglutide) is GLP-1 only. Clinical trials suggest Mounjaro may produce slightly more weight loss on average (15–21% vs ~15% for Wegovy), but individual results vary. Both require 16–20 weeks to reach maximum doses. Direct comparisons must always be individualised.
Can I get Mounjaro on the NHS in the UK?
Yes, NICE has approved tirzepatide (Mounjaro) for use in NHS specialist weight management services (tier 3). You need referral from your GP and assessment by the specialist service. Eligibility requires BMI ≥30 or BMI ≥27 with weight-related health conditions. NHS availability and waiting times vary significantly by region—contact your local ICB for information.
What if I don't lose weight after 12 weeks on Mounjaro?
If minimal weight loss occurs by week 12, your prescriber will assess whether Mounjaro is working for you. This may involve checking adherence to diet and exercise, reviewing side effects that could affect tolerability, or considering dose adjustments. Some people require higher doses (10–15 mg) to see results. Your healthcare provider can advise on next steps.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.